American Century Companies’s Larimar Therapeutics LRMR Stock Holding History

American Century Companies's LRMR Position: Q2 2026 in Review

American Century Companies reduced its Larimar Therapeutics (LRMR) stake by 66% in Q2 2026, selling an estimated $203K and leaving 26,467 shares worth $80.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2846.

American Century Companies first reported a position in LRMR in Q3 2023 and has held it in 12 quarters since. The position peaked at $349K in Q1 2026. 150 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

• American Century Companies held 26,467 shares of Larimar Therapeutics worth $80.7K as of Q2 2026.
• American Century Companies sold 51,169 Larimar Therapeutics shares in Q2 2026, an estimated $203K.
• Larimar Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2846 holding.
• American Century Companies first reported a position in Larimar Therapeutics in Q3 2023 and has held it in 12 quarters since.
• American Century Companies's Larimar Therapeutics position peaked at $349K in Q1 2026.
• 150 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.